Brian Taylor Slingsby's Insider Trades & SAST Disclosures
Brian Taylor Slingsby's most recent trade in Mineralys Therapeutics Inc was a trade of 259,259 Common Stock done at an average price of $13.5 . Disclosure was reported to the exchange on March 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brian Taylor Slingsby.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.50 per share. | 13 Mar 2025 | 259,259 | 8,903,838 | - | 13.5 | 3,499,997 | Common Stock |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 32,900 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 13 Feb 2025 | 32,900 | 0 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.05 per share. | 24 Jul 2024 | 550,000 | 8,644,579 | - | 13.1 | 7,177,500 | Common Stock |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 May 2024 | 22,000 | 22,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 22 May 2024 | 22,000 | 0 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 88,000 | 88,000 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Jul 2023 | 44,000 | 0 | - | - | Stock Option | |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 4,314,093 | 8,944,579 | - | - | Common Stock | ||
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 2,171,342 | 0 | - | - | Series A Preferred Stock | ||
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | 14 Feb 2023 | 2,142,751 | 0 | - | - | Series B Preferred Stock | ||
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 14 Feb 2023 | 250,000 | 9,194,579 | - | 16 | 4,000,000 | Common Stock |
| Mineralys Therapeutics Inc | Brian Taylor Slingsby | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 44,000 | 44,000 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges